Data / Form D filings / Autoimmunity Biologic Solutions Inc.
Autoimmunity Biologic Solutions Inc.: Form D filings
Autoimmunity Biologic Solutions Inc., a biotechnology company in Houston, TX, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on May 6, 2026, reports $3.2 million sold of a $3.2 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2710 REED RD, SUITE 160, Houston, TX, 77051
- Phone
- (787) 420-7613
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2045812
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | Amendment | $3,209,233 | $3,209,233 | 15 | Nov 8, 2024 | sec.gov | |
| Nov 22, 2024 | New notice | $2,210,242 | $2,210,242 | 12 | Nov 8, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gaddiel Galarza-Munoz | Executive Officer | |
| Eugene Williams | Executive Officer, Director | |
| Brock Reeve | Director | |
| Jimmy Lu | Director | |
| Mariano Garcia-Blanco | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Autoimmunity Biologic Solutions Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.